medroxyprogesterone acetate has been researched along with Hemorrhage, Uterine in 103 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (9.71) | 18.7374 |
1990's | 34 (33.01) | 18.2507 |
2000's | 48 (46.60) | 29.6817 |
2010's | 8 (7.77) | 24.3611 |
2020's | 3 (2.91) | 2.80 |
Authors | Studies |
---|---|
Angsuwathana, S; Indhavivadhana, S; Rattanachaiyanont, M; Soontrapa, N; Tanmahasamut, P; Techatraisak, K; Warnnissorn, M; Wongwananuruk, T | 1 |
Bender, RA | 1 |
Ali, T; Almuqbil, M; Alshehri, AM; Alshehri, S; Amin, F; Ara, R; Bader, GN; Hamid, L; Malik, A; Mir, SA; Shakeel, F; Wani, SUD | 1 |
Abreu, P; Andrews, E; Kagan, R | 1 |
Ankarali, H; Caglar, M; Mesci-Haftaci, S; Yavuzcan, A | 1 |
Basar, M; Guzeloglu-Kayisli, O; Joseph Huang, S; Kayisli, UA; Lockwood, CJ; Ozer, HG; Schatz, F; Shapiro, JP; Suarez, AA | 1 |
Basar, M; Guzeloglu Kayisli, O; Kayisli, UA; Lockwood, CJ; Schatz, F; Semerci, N | 1 |
Senthong, AJ; Taneepanichskul, S | 1 |
Celik, HH; Erbas, D; Kilic, S; Kormaz, A; Lortlar, N; Omeroglu, S; Peker, T; Tatar, I; Zulfikaroglu, E | 1 |
Huang, ZR; Li, XT; Wang, CY | 1 |
Bozorgmanesh, M; Ghaderi, L; Jalilian, N; Modarresi, M; Rezaie, M | 1 |
Ammerman, SR; Nelson, AL | 1 |
Cardenas, LH; Darney, PD; Goldberg, AB; Hubbard, AE | 1 |
Langer, RD; Lindenfeld, EA | 1 |
Liu, JH; Shumel, BS; Simon, JA; Speroff, L; Symons, JP | 1 |
Chayama, K; Higashi, Y; Kimura, M; Kodama, I; Nakagawa, K; Ohama, K; Sanada, M; Tsuda, M | 1 |
Charuruks, N; Chotnopparatpattara, P; Taneepanichskul, S; Treratanachat, S | 1 |
Binder, EF; Bronder, DR; Kohrt, WM; Pinto, AB; Williams, DB | 1 |
Hendrix, SL; Learman, LA; Lin, F; Richter, HE; Summitt, RL; Varner, RE; Washington, AE | 1 |
BURSTEIN, R; WASSERMAN, HC | 1 |
Felix, JC; Jain, JK; Kuo, J; Lu, JJ; Nicosia, AF; Nucatola, DL | 1 |
Hulley, SB; Ireland, CC; Kuppermann, M; Learman, LA; Richter, HE; Summitt, RL; Varner, RE; Vittinghoff, E; Washington, E | 1 |
Chotnopparatpattara, P; Fraser, IS; Markham, R; Russell, P; Sereepapong, W; Taneepanichskul, S | 1 |
Adams-Campbell, LL; Ascensao, J; Chen, C; Chlebowski, RT; Harris, R; Hubbell, FA; Ritenbaugh, C; Rodabough, RJ; Rosenberg, CA; Taylor, VM; Wactawski-Wende, J; White, E | 1 |
Hulley, SB; Ireland, C; Kuppermann, M; Learman, LA; Lin, F; Richter, HE; Showstack, J; Stewart, AL; Summitt, RL; Varner, RE; Vittinghoff, E; Washington, AE | 1 |
Engelstein, M; Kuhl, H; Mäenpää, J; Mattila, L; Mustonen, M; Rees, MC | 1 |
Heikkinen, J; Mäenpää, J; Mattsson, LA; Skouby, SO; Timonen, U; Vaheri, R | 1 |
Bode, FR; Jain, J; Jakimiuk, AJ; Kaunitz, AM; Ross, D | 1 |
Taneepanichskul, S; Tantiwattanakul, P | 1 |
Bäckström, T; Dahmoun, M; Karlsson, MG; Odmark, IS; Pavlenko, T; Risberg, B | 1 |
Kazerooni, T; Zolghadri, J | 1 |
Lei, ZW; Lü, JQ; Sun, J; Xu, XW; Zhou, J | 1 |
Eren, S; Pekin, O; Tugrul, S; Uslu, H; Yildirim, G | 1 |
Bergqvist, A; Carson, SA; Luciano, A; Ross, D; Schlaff, WD | 1 |
Helmond, FA; Landgren, BM; Langer, RD; Rymer, J | 1 |
Arias, RD; Brucker, C; Jain, JK; Ray, A; Ross, D | 1 |
Barreda, L; Basu, R; Brisinger, M; Mainor, N; Munro, MG | 1 |
Soper, DE; Thurman, AR | 1 |
Archer, DF; den Hollander, W; Ferenczy, A; Gallagher, JC; Helmond, FA; Hendrix, S; Rymer, J; Skouby, S; Stathopoulos, V | 1 |
Felix, JC; Jain, JK; Li, A; Minoo, P; Xiong, DW; Yang, W | 1 |
Elder, MG | 1 |
Flowers, CE; Hyde, BM; Wilborn, WH | 1 |
Paskowitz, RA | 1 |
Aono, T; Hata, K; Irahara, M; Sunahara, S; Uemura, H; Yasui, T; Yoneda, N | 1 |
Haverkorn, MJ; Meuwissen, JH; Wiegerinck, MA | 1 |
Nand, SL; Webster, MA; Wren, BG | 1 |
Fu, YS; Judd, HL; Schoenfeld, MJ; Voigt, BJ; Williams, DB | 1 |
Faure, N; Lemay, A | 1 |
Blumenthal, NJ; Jacobs, SA | 1 |
Valle, RF | 1 |
Nicholas, SL; Rulin, MC | 1 |
Archer, DF; Bottiglioni, F; Pickar, JH | 2 |
Liu, JL | 1 |
Boyd, ME; Colgan, TJ; Ferenczy, A; Fugere, P; Lorrain, J; Ross, AH | 1 |
Cuong, DT; My Huong, NT | 1 |
AinMelk, Y | 1 |
Affandi, B; Belsey, EM; d'Arcangues, C; Dusitsin, N; Hadisaputra, W; Kazi, A; Kirwat, O; Koetsawang, S; Noonan, E; Olayinka, I; Pinol, A; Piya-Anant, M; Ramos, RM; Rocca, M; Sadek, W; Said, S; Sethavanich, S | 1 |
Geurts, P; Hirvonen, E; Lamberg-Allardt, C; Lankinen, KS; Wilén-Rosenqvist, G | 1 |
Dunson, TR; Nutley, T | 1 |
Betz, M; Cañamar, R; Dalberth, BT; Potter, LS | 1 |
d'Arcangues, C; Dinchuen, P; Koetsawang, S; Patrasupapong, N; Piaggio, G; Pinol, A; Piya-Anant, M | 1 |
Baber, R; Nand, SL; O'Connor, V; Webster, MA | 1 |
Borgatta, L | 1 |
Hill, DA | 1 |
Gruss, J; Keder, LM; Rulin, MC | 1 |
Büyük, E; Dökmeci, C; Durmuşoğlu, F | 1 |
Colli, E; Parazzini, F; Penhallegon, R; Tong, D | 1 |
Affandi, B; Kovacs, G; Ostor, A; Rogers, PA; Salamonsen, LA; Vincent, AJ; Zhang, J | 2 |
Jaszczak, P; Planellas, J; Poulsen, HK; Saure, A | 1 |
Phaosavadi, S; Reinprayoon, D; Taneepanichskul, S | 1 |
Gillmer, MD; Gray, W; Rai, VS | 1 |
Abdul Madjid, O; Affandi, B; Sabariah, S; Subakir, SB | 1 |
Salamonsen, LA; Vincent, AJ | 1 |
Demopolous, R; Krikun, G; Lockwood, CJ; Runic, R; Schatz, F; Wan, L | 1 |
Archer, DF; Pickar, JH | 1 |
Garceau, RJ; Kaunitz, AM; Wajszczuk, CJ | 1 |
Clark, MK; Levy, BT; Sowers, M; Tenhundfeld, P | 1 |
Archer, DF; Dorin, M; Lewis, V; Pickar, JH; Schneider, DL | 1 |
Kaunitz, AM | 1 |
Aono, T; Irahara, M; Kamada, M; Kinoshita, H; Kiyokawa, M; Tezuka, M; Uemura, H; Yamada, M; Yasui, T | 1 |
Bruhat, M; Kainulainen, P; Rudolf, K; Timonen, U; Vaheri, R; Viitanen, A | 1 |
Aono, T; Irahara, M; Miura, M; Tezuka, M; Uemura, H; Yamada, M; Yasui, T | 1 |
Anthony, MS; Blair, RM; Clarkson, TB; Cline, JM | 1 |
Bäckström, AC; Crona, N; Hirvonen, E; Wahlström, T | 1 |
Mastrantonio, P; Morelli, M; Noia, R; Palomba, S; Sena, T; Zullo, F | 1 |
Baracat, EC; Barbosa, IC; Giordano, MG; Haidar, MA; Marinho, RM; Menegocci, JC; Morais, KM; Tomaz, G; Wehba, S | 1 |
Anttila, L; Erkkola, R; Irjala, K; Kaihola, HL; Koskinen, P; Ruutiainen, K | 1 |
Fraser, DI; Hillard, TC; Pryse-Davies, J; Siddle, NC; Whitehead, MI | 1 |
Byrjalsen, I; Christiansen, C; Meinecke, B; Riis, BJ; Thormann, L | 1 |
Crona, N; Mattsson, LA; Rybo, G; Sporrong, T; Vilbergson, G | 1 |
Campodónico, I; Valdivia, I | 1 |
Sapire, KE | 1 |
Clisham, PR; de Ziegler, D; Judd, HL; Lozano, K | 1 |
Goldrath, MH | 1 |
Aizawa, M; Houjou, T; Kadota, K; Kurooka, K; Matunami, N; Mori, N; Morikawa, E; Nakano, K; Wada, T; Yamato, M | 1 |
Donát, J; Reslová, T | 1 |
Bewtra, C; Gallagher, JC; Kable, WT | 1 |
Bonte, J; Ide, P; Janssens, JP | 1 |
Hellberg, D; Nilsson, S | 1 |
Ajmal, F; Benitez, IB; Kazi, A; Kiriwat, O; Koetsawang, S; Omar, K; Pretnar-Darovec, A; Said, S; Srisatayapan, Y; Wynter, HH | 1 |
Barnhill, D; Dames, J; Gallup, D; Heller, P; Hoskins, W; Park, R | 1 |
4 review(s) available for medroxyprogesterone acetate and Hemorrhage, Uterine
Article | Year |
---|---|
Endometrial ablation for dysfunctional uterine bleeding: role of GNRH agonists.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Catheter Ablation; Endometrium; Female; Humans; Hysterectomy; Laser Therapy; Leuprolide; Medroxyprogesterone Acetate; Menorrhagia; Menstruation; Premedication; Uterine Hemorrhage | 1993 |
Managing clinical complexities of long-term contraception.
Topics: Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Uterine Hemorrhage | 1998 |
The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestin-only contraceptives.
Topics: Biopsy; Contraceptive Agents, Female; Endometrium; Female; Humans; Leukocytes; Levonorgestrel; Matrix Metalloproteinases; Medroxyprogesterone Acetate; Progestins; Uterine Hemorrhage | 2000 |
Lunelle monthly injectable contraceptive. An effective, safe, and convenient new birth control option.
Topics: Contraception; Contraceptive Agents, Female; Drug Administration Schedule; Estradiol; Female; Fertility; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Patient Satisfaction; Pregnancy; Progesterone; Time Factors; Treatment Outcome; Uterine Hemorrhage | 2001 |
59 trial(s) available for medroxyprogesterone acetate and Hemorrhage, Uterine
Article | Year |
---|---|
The effectiveness of desogestrel for endometrial protection in women with abnormal uterine bleeding-ovulatory dysfunction: a non-inferiority randomized controlled trial.
Topics: Adult; Desogestrel; Double-Blind Method; Endometrium; Female; Humans; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Ovary; Ovulation; Progestins; Prospective Studies; Thailand; Time Factors; Treatment Outcome; Uterine Hemorrhage | 2022 |
Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial.
Topics: Female; Humans; Medroxyprogesterone Acetate; Prospective Studies; Quality of Life; Selective Estrogen Receptor Modulators; Uterine Hemorrhage | 2022 |
Vaginal bleeding/spotting with conjugated estrogens/bazedoxifene, conjugated estrogens/medroxyprogesterone acetate, and placebo.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Indoles; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Selective Estrogen Receptor Modulators; Uterine Hemorrhage | 2018 |
The effect of tranexamic acid for treatment irregular uterine bleeding secondary to DMPA use.
Topics: Adult; Antifibrinolytic Agents; Contraceptive Agents, Female; Double-Blind Method; Endometrium; Female; Humans; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Pregnancy; Tranexamic Acid; Ultrasonography; Uterine Hemorrhage | 2009 |
[Effects of taking estrogen and progestogen after medical abortion on reducing vaginal hemorrhage time: a randomized-controlled trial].
Topics: Abortion, Induced; Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Pregnancy; Uterine Hemorrhage; Young Adult | 2011 |
Phytotherapeutic management of polycystic ovary syndrome: role of aerial parts of wood betony (Stachys lavandulifolia).
Topics: Adolescent; Adult; Female; Humans; Linear Models; Medroxyprogesterone Acetate; Phytotherapy; Plant Components, Aerial; Polycystic Ovary Syndrome; Stachys; Uterine Hemorrhage; Young Adult | 2013 |
A new progestogen-only medical therapy for outpatient management of acute, abnormal uterine bleeding: a pilot study.
Topics: Acute Disease; Adult; Contraceptive Agents, Female; Feasibility Studies; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Middle Aged; Outpatients; Patient Satisfaction; Pilot Projects; Prospective Studies; Treatment Outcome; Uterine Hemorrhage; Young Adult | 2013 |
Post-abortion depot medroxyprogesterone acetate continuation rates: a randomized trial of cyclic estradiol.
Topics: Abortion, Induced; Administration, Cutaneous; Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Double-Blind Method; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Patient Compliance; Placebos; Pregnancy; Uterine Hemorrhage | 2002 |
Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Topics: Adult; Amenorrhea; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Time Factors; Uterine Hemorrhage | 2003 |
Effects of trimonthly progestin administration on the endometrium in elderly postmenopausal women who receive hormone replacement therapy: a pilot study.
Topics: Aged; Biopsy; Double-Blind Method; Endometrial Hyperplasia; Endometrium; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Pilot Projects; Placebos; Postmenopause; Progesterone Congeners; Prospective Studies; Ultrasonography; Uterine Hemorrhage | 2003 |
Mifepristone for the prevention of breakthrough bleeding in new starters of depo-medroxyprogesterone acetate.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Endometrium; Estrogen Receptor alpha; Estrogens; Female; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Mifepristone; Ovulation; Progesterone; Random Allocation; Receptors, Estrogen; Receptors, Progesterone; Time Factors; Uterine Hemorrhage | 2003 |
Medicine or Surgery (Ms): a randomized clinical trial comparing hysterectomy and medical treatment in premenopausal women with abnormal uterine bleeding.
Topics: Adult; Black or African American; Contraceptives, Oral; Costs and Cost Analysis; Cyclooxygenase Inhibitors; Female; Humans; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Obesity; Patient Selection; Premenopause; Quality of Life; Uterine Hemorrhage | 2004 |
Estrogen plus progestin and colorectal cancer in postmenopausal women.
Topics: Aged; Colorectal Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Postmenopause; Uterine Hemorrhage | 2004 |
Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial.
Topics: Adult; Cyclooxygenase Inhibitors; Estrogens; Female; Hormones; Humans; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Patient Satisfaction; Premenopause; Progesterone; Quality of Life; Sexual Behavior; Sickness Impact Profile; Treatment Outcome; Uterine Hemorrhage | 2004 |
Endometrial safety and tolerability of triphasic sequential hormone replacement estradiol valerate/medroxyprogesterone acetate therapy regimen.
Topics: Adult; Aged; Biopsy; Climacteric; Contraceptive Agents, Female; Double-Blind Method; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Ultrasonography; Uterine Hemorrhage | 2004 |
A low-dose start in hormone replacement therapy provides a beneficial bleeding profile and few side-effects: randomized comparison with a conventional-dose regimen.
Topics: Aged; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Uterine Hemorrhage | 2004 |
Contraceptive efficacy and safety of DMPA-SC.
Topics: Adult; Amenorrhea; Asia; Blood Pressure; Body Mass Index; Body Weight; Contraceptive Agents, Female; Europe; Female; Humans; Injections, Subcutaneous; Medroxyprogesterone Acetate; Patient Satisfaction; Pregnancy; United States; Uterine Hemorrhage | 2004 |
Effect of mefenamic acid on controlling irregular uterine bleeding in DMPA users.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Contraceptive Agents, Female; Double-Blind Method; Female; Humans; Medroxyprogesterone Acetate; Mefenamic Acid; Placebos; Uterine Hemorrhage | 2004 |
Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
Topics: Apoptosis; Biopsy; Cell Proliferation; Endometrium; Estradiol; Estrogen Receptor alpha; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Ki-67 Antigen; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Receptors, Progesterone; Regression Analysis; Sweden; Uterine Hemorrhage | 2004 |
The comparison of bleeding patterns with high-dose and low-dose hormone replacement therapy in postmenopausal women.
Topics: Amenorrhea; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone Acetate; Middle Aged; Placebos; Postmenopause; Time Factors; Uterine Hemorrhage | 2004 |
Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
Topics: Adult; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Time Factors; Uterine Hemorrhage | 2006 |
Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
Topics: Adult; Bone Density; Delayed-Action Preparations; Endometriosis; Estrogens; Female; Flushing; Humans; Injections, Subcutaneous; Leuprolide; Medroxyprogesterone Acetate; Pain; Palliative Care; Quality of Life; Single-Blind Method; Treatment Outcome; Uterine Hemorrhage | 2006 |
Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
Topics: Aged; Biopsy; Contraceptive Agents, Female; Double-Blind Method; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Endometrium; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Osteoporosis; Ultrasonography; Uterine Hemorrhage | 2006 |
Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg.
Topics: Adult; Amenorrhea; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Injections, Subcutaneous; Medroxyprogesterone Acetate; Menstrual Cycle; Uterine Hemorrhage | 2006 |
Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Female; Humans; Medroxyprogesterone Acetate; Patient Satisfaction; Patient Selection; Uterine Hemorrhage | 2006 |
Endometrial effects of tibolone.
Topics: Aged; Carcinoma; Cohort Studies; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Pain; Uterine Hemorrhage | 2007 |
Effect of mifepristone on endometrial matrix metalloproteinase expression and leukocyte abundance in new medroxyprogesterone acetate users.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; DNA Primers; Double-Blind Method; Endometrium; Female; Humans; Immunohistochemistry; Leukocytes; Matrix Metalloproteinases; Medroxyprogesterone Acetate; Middle Aged; Mifepristone; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Treatment Outcome; Uterine Hemorrhage | 2007 |
Continuous combined piperazine oestrone sulphate and medroxyprogesterone acetate hormone replacement therapy--a study of bleeding pattern, endometrial response, serum lipid and bone density changes.
Topics: Administration, Oral; Bone Density; Drug Therapy, Combination; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Pilot Projects; Uterine Hemorrhage | 1995 |
Assessment of less than monthly progestin therapy in postmenopausal women given estrogen replacement.
Topics: Adult; Aged; Cholesterol; Endometrial Hyperplasia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Triglycerides; Uterine Hemorrhage | 1994 |
Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
Topics: Adult; Aged; Double-Blind Method; Drug Administration Schedule; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Prospective Studies; Uterine Hemorrhage | 1994 |
Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Biopsy; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrium; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Prospective Studies; Uterine Hemorrhage | 1993 |
Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and Cyclofem, in Vietnamese women.
Topics: Adult; Blood Pressure; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Life Tables; Longitudinal Studies; Medroxyprogesterone Acetate; Menstruation Disturbances; Multicenter Studies as Topic; Patient Dropouts; Patient Selection; Treatment Refusal; Uterine Hemorrhage; Vietnam | 1996 |
Comparison of two continuous combined estrogen progestogen regimens in postmenopausal women: a randomized trial.
Topics: Blood Pressure; Drug Combinations; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Prospective Studies; Ultrasonography; Uterine Hemorrhage | 1996 |
Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Developmen
Topics: Adolescent; Adult; Contraceptive Agents, Female; Double-Blind Method; Estradiol Congeners; Estrogens, Conjugated (USP); Estrone; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone Acetate; Menstruation; Time Factors; Treatment Outcome; Uterine Hemorrhage | 1996 |
Transdermal oestradiol gel in the treatment of the climacterium: a comparison with oral therapy.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Bone Density; Cholesterol; Climacteric; Estradiol; Estrogen Replacement Therapy; Female; Gels; Hot Flashes; Humans; Medroxyprogesterone Acetate; Middle Aged; Progesterone Congeners; Sweating; Treatment Refusal; Uterine Hemorrhage | 1997 |
Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
Topics: Adult; Amenorrhea; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Follow-Up Studies; Humans; Incidence; Medroxyprogesterone Acetate; Patient Dropouts; Progesterone Congeners; Time Factors; Uterine Hemorrhage | 1998 |
Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy. The Ogen/Provera Study Group.
Topics: Adult; Biopsy, Needle; Double-Blind Method; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Uterine Hemorrhage | 1998 |
Compliance with depot medroxyprogesterone acetate: a randomized, controlled trial of intensive reminders.
Topics: Adult; Body Weight; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Therapy, Computer-Assisted; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Patient Compliance; Patient Dropouts; Patient Satisfaction; Uterine Hemorrhage | 1998 |
Effect of initial gestagen treatment on bleeding patterns in postmenopausal women receiving continuous combined hormone replacement therapy.
Topics: Adult; Drug Therapy, Combination; Dysmenorrhea; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progestins; Prospective Studies; Treatment Outcome; Uterine Hemorrhage | 1999 |
A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women.
Topics: Administration, Oral; Blood Pressure; Climacteric; Desogestrel; Double-Blind Method; Estradiol; Estrogens, Conjugated (USP); Female; Flushing; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Mood Disorders; Placebos; Progesterone Congeners; Sweating; Uterine Hemorrhage | 2000 |
DMPA use above the age of 35 in Thai women.
Topics: Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Injections; Medroxyprogesterone Acetate; Parity; Thailand; Uterine Hemorrhage | 2000 |
Is endometrial pre-treatment of value in improving the outcome of transcervical resection of the endometrium?
Topics: Amenorrhea; Danazol; Endometrium; Estrogen Antagonists; Female; Hormones; Humans; Medroxyprogesterone Acetate; Menorrhagia; Nafarelin; Patient Satisfaction; Premedication; Prospective Studies; Treatment Outcome; Uterine Hemorrhage | 2000 |
Hormone replacement therapy: effect of progestin dose and time since menopause on endometrial bleeding.
Topics: Aged; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Patient Acceptance of Health Care; Uterine Hemorrhage | 2000 |
Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other
Topics: Adolescent; Adult; Amenorrhea; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Mestranol; Middle Aged; Norethindrone; Patient Compliance; Uterine Hemorrhage | 2000 |
Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding.
Topics: Amenorrhea; Animals; Cohort Studies; Double-Blind Method; Endometrium; Estrogens, Conjugated (USP); Female; Horses; Humans; Medroxyprogesterone Acetate; Treatment Outcome; Uterine Hemorrhage | 2001 |
Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotropin-releasing hormone agonists treatment in women with endometriosis.
Topics: Adult; Animals; Bone Density; Bone Remodeling; CA-125 Antigen; Endometriosis; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Gonadotropin-Releasing Hormone; Horses; Humans; Leuprolide; Medroxyprogesterone Acetate; Middle Aged; Uterine Hemorrhage | 2001 |
Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study.
Topics: Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometrium; Estradiol; Female; France; Germany; Hormone Replacement Therapy; Hot Flashes; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Compliance; Surveys and Questionnaires; Treatment Outcome; Triglycerides; Uterine Hemorrhage | 2001 |
Biological effects of hormone replacement therapy in relation to serum estradiol levels.
Topics: Adult; Bone Density; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Humans; Lipids; Lumbar Vertebrae; Luteinizing Hormone; Medroxyprogesterone Acetate; Middle Aged; Ovariectomy; Postmenopause; Progesterone Congeners; Uterine Hemorrhage | 2001 |
Effect of an estradiol gel with monthly or quarterly progestogen on menopausal symptoms and bleeding.
Topics: Administration, Cutaneous; Administration, Oral; Drug Administration Schedule; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Finland; Gels; Hot Flashes; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Sweden; Treatment Outcome; Uterine Hemorrhage; Vasomotor System; Women's Health | 2000 |
Amenorrhea frequency with continuous combined hormone replacement therapy: a retrospective analysis. Menopause Study Group.
Topics: Amenorrhea; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Prospective Studies; Retrospective Studies; Uterine Hemorrhage | 1998 |
Effect of different doses of progestin on uterine leiomyomas in postmenopausal women.
Topics: Amenorrhea; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Postmenopause; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms | 2002 |
A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
Topics: Aged; Animals; Coitus; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Horses; Hot Flashes; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Uterine Hemorrhage; Weight Gain | 2002 |
Sequential estrogen and progestogen therapy: assessment of progestational effects on the postmenopausal endometrium.
Topics: Desogestrel; Endometrium; Estradiol; Estradiol Dehydrogenases; Estrogen Replacement Therapy; Female; Glycodelin; Glycoproteins; Humans; Isocitrate Dehydrogenase; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Pregnancy Proteins; Progesterone Congeners; Uterine Hemorrhage | 1992 |
An objective and subjective assessment of uterine blood loss in postmenopausal women on hormone replacement therapy.
Topics: Climacteric; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Uterine Hemorrhage | 1992 |
A study of bleeding patterns with two injectable contraceptives given postpartum and the effect of two non-hormonal treatments.
Topics: Contraceptive Agents, Female; Double-Blind Method; Female; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Naproxen; Norethindrone; Postpartum Period; Pregnancy; Tranexamic Acid; Uterine Hemorrhage | 1991 |
Comparison of continuous versus sequential estrogen and progestin therapy in postmenopausal women.
Topics: Drug Administration Schedule; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pilot Projects; Uterine Hemorrhage | 1991 |
Endometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin.
Topics: Antineoplastic Agents; Biopsy; Double-Blind Method; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Gonadotropins, Pituitary; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prospective Studies; Random Allocation; Uterine Hemorrhage | 1988 |
Pilot study to evaluate a new regimen to treat climacteric complaints with cyclic combined oestradiol valerate/medroxyprogesterone acetate.
Topics: Adult; Climacteric; Clinical Trials as Topic; Drug Therapy, Combination; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pilot Projects; Uterine Hemorrhage | 1987 |
A multicentered phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: II. The comparison of bleeding patterns. World Health Organization. Task Force on Long-Acting Systemic Agents for F
Topics: Amenorrhea; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Patient Compliance; Uterine Hemorrhage | 1987 |
40 other study(ies) available for medroxyprogesterone acetate and Hemorrhage, Uterine
Article | Year |
---|---|
Medroxyprogesterone Acetate for Abnormal Uterine Bleeding Due to Ovulatory Dysfunction: The Effect of 2 Different-Duration Regimens.
Topics: Clinical Protocols; Female; Humans; Medroxyprogesterone Acetate; Menstrual Cycle; Quality of Life; Uterine Hemorrhage | 2022 |
Endometrial curettage in abnormal uterine bleeding and efficacy of progestins for control in cases of hyperplasia.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Curettage; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Treatment Outcome; Uterine Hemorrhage; Young Adult | 2014 |
Mass spectrometry identification of potential mediators of progestin-only contraceptive-induced abnormal uterine bleeding in human endometrial stromal cells.
Topics: Cells, Cultured; Contraceptive Agents, Female; Desogestrel; Endometrium; Estradiol; Female; Glycoproteins; Humans; Hypoxia; Mass Spectrometry; Medroxyprogesterone Acetate; Progestins; Stromal Cells; Thrombin; Uterine Hemorrhage | 2015 |
Progestins Upregulate FKBP51 Expression in Human Endometrial Stromal Cells to Induce Functional Progesterone and Glucocorticoid Withdrawal: Implications for Contraceptive- Associated Abnormal Uterine Bleeding.
Topics: Animals; Contraceptive Agents, Female; Desogestrel; Endometrium; Female; Glucocorticoids; Guinea Pigs; Humans; Interleukin-1beta; Medroxyprogesterone Acetate; Multigene Family; Progesterone; Progestins; RNA, Messenger; Stromal Cells; Tacrolimus Binding Proteins; Up-Regulation; Uterine Hemorrhage | 2015 |
The long-term effects of progesterone-only contraceptives on endometrium and ovary in rats.
Topics: Animals; Contraceptive Agents, Female; Delayed-Action Preparations; Desogestrel; Disease Models, Animal; Endometrium; Female; Medroxyprogesterone Acetate; Ovary; Progesterone; Rats; Rats, Wistar; Time Factors; Uterine Hemorrhage | 2010 |
Bleeding patterns of the hormone replacement therapies in the postmenopausal estrogen and progestin interventions trial.
Topics: Aged; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Progesterone; Uterine Hemorrhage | 2002 |
A comparison of low-dose and standard-dose oral estrogen on forearm endothelial function in early postmenopausal women.
Topics: Administration, Oral; Cholesterol, LDL; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Forearm; Hemodynamics; Humans; Medroxyprogesterone Acetate; Middle Aged; Nitrates; Nitrites; Postmenopause; Uterine Hemorrhage | 2003 |
Relationship between progesterone receptor level in endometrium and bleeding pattern in depot medroxyprogesterone acetate users.
Topics: Adult; Amenorrhea; Biomarkers; Case-Control Studies; Cohort Studies; Contraceptive Agents, Female; Endometrium; Female; Humans; Incidence; Medroxyprogesterone Acetate; Probability; Progesterone; Reference Values; Risk Assessment; Sensitivity and Specificity; Uterine Hemorrhage | 2003 |
Medroxyprogesterone acetate treatment of abnormal uterine bleeding: factors predicting satisfaction.
Topics: Adult; Age Factors; Female; Humans; Medroxyprogesterone Acetate; Menstrual Cycle; Middle Aged; Odds Ratio; Patient Satisfaction; Premenopause; Progesterone Congeners; Prospective Studies; Sterilization, Tubal; Time Factors; Uterine Hemorrhage | 2003 |
THE EFFECT OF PROVERA ON THE FETUS.
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Drug Therapy; Female; Fetus; Humans; Infant, Newborn; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Complications; Pregnancy Complications, Hematologic; Pregnancy Tests; Toxicology; Uterine Hemorrhage; Virilism | 1964 |
Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users.
Topics: Adult; Amenorrhea; Case-Control Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Endometrium; Female; Humans; Medroxyprogesterone Acetate; Receptors, Estrogen; Receptors, Progesterone; Stromal Cells; Uterine Hemorrhage | 2004 |
[Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
Topics: Adult; Combined Modality Therapy; Delayed-Action Preparations; Drug Administration Schedule; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Laparoscopy; Leuprolide; Luteinizing Hormone; Medroxyprogesterone Acetate; Treatment Outcome; Uterine Hemorrhage | 2005 |
Endometrial histology of Depomedroxyprogesterone acetate users: a pilot study.
Topics: Adult; Amenorrhea; Contraceptive Agents, Female; Endometritis; Endometrium; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Pilot Projects; Uterine Hemorrhage | 2006 |
Injectable contraception.
Topics: Adult; Cervix Mucus; Contraceptive Agents, Female; Endometrium; Female; Humans; Injections, Intramuscular; Kinetics; Lactation; Lipid Metabolism; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Uterine Hemorrhage | 1984 |
Mechanisms of uterine bleeding in postmenopausal patients receiving estrogen alone or with a progestin.
Topics: Adult; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Histocytochemistry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Microscopy, Electron; Middle Aged; Norethindrone; Norethindrone Acetate; Substance Withdrawal Syndrome; Uterine Hemorrhage | 1983 |
"Rollerball" ablation of the endometrium.
Topics: Electrocoagulation; Endometrium; Female; Humans; Hysterectomy; Leuprolide; Life Tables; Medroxyprogesterone Acetate; Menorrhagia; Norethindrone; Norethindrone Acetate; Postoperative Complications; Reoperation; Uterine Hemorrhage | 1995 |
[Assessment of serum estrogen levels by RIA with HPLC during hormone replacement therapy].
Topics: Adult; Chromatography, High Pressure Liquid; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Radioimmunoassay; Uterine Hemorrhage | 1995 |
Regression of endometrial thickness in combination with reduced withdrawal bleeding as a progestational effect of tibolone in postmenopausal women on oestrogen replacement therapy.
Topics: Adult; Aged; Endometrium; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Progestins; Uterine Hemorrhage | 1995 |
Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
Topics: Administration, Cutaneous; Adolescent; Adult; Androstenedione; Drug Implants; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Medroxyprogesterone Acetate; Pilot Projects; Polycystic Ovary Syndrome; Progesterone; Testosterone; Uterine Hemorrhage | 1994 |
Endometrial resection follow up: late onset of pain and the effect of depot medroxyprogesterone acetate.
Topics: Adult; Endometrium; Female; Follow-Up Studies; Humans; Length of Stay; Medroxyprogesterone Acetate; Middle Aged; Pain, Postoperative; Patient Satisfaction; Time Factors; Treatment Outcome; Uterine Hemorrhage | 1994 |
Acute vaginal bleeding in women undergoing liver transplantation.
Topics: Acute Disease; Adult; Blood Transfusion; Female; Humans; Hysterectomy; Liver Diseases; Liver Transplantation; Medroxyprogesterone Acetate; Middle Aged; Postoperative Complications; Progestins; Retrospective Studies; Uterine Hemorrhage | 1994 |
[Effect of nylestriol on postmenopausal uterine endometrium].
Topics: Aged; Endometrium; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Quinestrol; Uterine Hemorrhage | 1993 |
Treatment of bleeding problems associated with progestin-only contraceptives: survey results.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Implants; Estrogens; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Surveys and Questionnaires; Uterine Hemorrhage | 1997 |
Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Injections; Medroxyprogesterone Acetate; North Carolina; Patient Satisfaction; Retrospective Studies; Time Factors; Uterine Hemorrhage | 1997 |
Gynecology case challenge: vaginal bleeding in a woman taking an injectable contraceptive.
Topics: Adult; Contraceptive Agents, Female; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Polyps; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms; Uterus | 1998 |
Reasons for contraceptive discontinuation in women 20-39 years old in New Zealand.
Topics: Adult; Cohort Studies; Contraceptives, Oral; Delayed-Action Preparations; Female; Humans; Infections; Intrauterine Devices; Medroxyprogesterone Acetate; Menorrhagia; New Zealand; Patient Satisfaction; Pelvic Pain; Pregnancy; Uterine Hemorrhage; Vasectomy | 1999 |
Matrix metalloproteinase-1 and -3 and mast cells are present in the endometrium of women using progestin-only contraceptives.
Topics: Adult; Biopsy; Contraceptive Agents, Female; Delayed-Action Preparations; Endometrium; Female; Humans; Immunohistochemistry; Levonorgestrel; Mast Cells; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Medroxyprogesterone Acetate; Middle Aged; Progesterone Congeners; Uterine Hemorrhage | 2000 |
Oxidative stress, vitamin E and progestin breakthrough bleeding.
Topics: Adolescent; Adult; Biopsy; Cells, Cultured; Endometrium; Endothelium, Vascular; Female; Humans; Levonorgestrel; Lipid Peroxides; Medroxyprogesterone Acetate; Neovascularization, Physiologic; Oxidative Stress; Progestins; Uterine Hemorrhage; Vitamin E | 2000 |
The role of tissue factor in regulating endometrial haemostasis: implications for progestin-only contraception.
Topics: Biopsy; Blotting, Western; Contraceptive Agents, Female; Endometrium; ErbB Receptors; Female; Hemostasis; Humans; Hysteroscopy; Immunohistochemistry; Medroxyprogesterone Acetate; Progestins; Receptors, Progesterone; Stromal Cells; Thromboplastin; Uterine Hemorrhage | 2000 |
Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception.
Topics: Adult; Age Factors; Contraceptive Agents, Female; Delayed-Action Preparations; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Parity; Progesterone; Progesterone Congeners; Prospective Studies; Statistics, Nonparametric; Time Factors; Uterine Hemorrhage | 2001 |
Use of the progestin challenge test in nonhuman primates (Macaca fascicularis).
Topics: Animals; Cross-Over Studies; Endometrium; Estradiol; Female; Macaca fascicularis; Medroxyprogesterone Acetate; Progesterone; Progesterone Congeners; Random Allocation; Uterine Hemorrhage | 2002 |
Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uter
Topics: Contraceptive Agents, Female; Delayed-Action Preparations; Endometrium; Female; Humans; Leukocytes; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Protein Isoforms; Tissue Inhibitor of Metalloproteinases; Uterine Hemorrhage | 2002 |
Serum androgen and gonadotropin levels decline after progestogen-induced withdrawal bleeding in oligomenorrheic women with or without polycystic ovaries.
Topics: Adolescent; Adult; Androgens; Female; Gonadotropins, Pituitary; Humans; Medroxyprogesterone Acetate; Oligomenorrhea; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Substance Withdrawal Syndrome; Uterine Hemorrhage | 1992 |
Continuous combined conjugated equine estrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis.
Topics: Amenorrhea; Atrophy; Drug Therapy, Combination; Endometrium; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Time Factors; Uterine Hemorrhage | 1992 |
[Cyclic ethinyl estradiol and medroxyprogesterone in climacteric women. Their clinicAL efficacy and patterns of uterine bleeding].
Topics: Climacteric; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Progesterone; Uterine Hemorrhage; Vaginal Smears | 1991 |
Use of danazol in hysteroscopic surgery for menorrhagia.
Topics: Adolescent; Adult; Danazol; Drug Synergism; Endometriosis; Female; Humans; Hysteroscopy; Laser Therapy; Medroxyprogesterone; Medroxyprogesterone Acetate; Menorrhagia; Middle Aged; Pregnadienes; Premedication; Uterine Hemorrhage; Warfarin | 1990 |
[Combination therapy with medroxyprogesterone acetate and tegafur in tamoxifen- and adriamycin-resistant advanced breast cancers].
Topics: Adult; Aged; Breast Neoplasms; Doxorubicin; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Obesity; Receptors, Estrogen; Receptors, Progesterone; Remission Induction; Tamoxifen; Tegafur; Uterine Hemorrhage | 1989 |
[Initial experience with centralized care of women with bleeding in the climacteric and postmenopausal period].
Topics: Climacteric; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Uterine Hemorrhage | 1989 |
Modalities and results of a combined anti-estrogenic therapy by means of tamoxifen and medroxyprogesterone in gynecologic cancerology.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Hemorrhage; Uterine Neoplasms | 1986 |
Persistence of endometrial activity after radiation therapy for cervical carcinoma.
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Dilatation and Curettage; Endometrium; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Hyperplasia; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovariectomy; Radiotherapy; Radiotherapy Dosage; Risk; Uterine Cervical Neoplasms; Uterine Hemorrhage; Uterine Neoplasms | 1985 |